| RS2114014389 |
TFAP2A
|
Health Risk |
Pathogenic |
— |
| RS2114014460 |
TFAP2A
|
Health Risk |
Likely pathogenic |
Branchiooculofacial syndrome, TFAP2A-related disorder |
| RS2114032531 |
GM2A
|
Health Risk |
Pathogenic |
Tay-Sachs disease, variant AB |
| RS2114236281 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114236416 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder 4A (Zellweger) |
| RS2114236937 |
PEX6
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS2114237186 |
PEX6
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114237595 |
PEX6
|
Health Risk |
Likely pathogenic |
— |
| RS2114238399 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114238521 |
PEX6
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114240428 |
PEX6
|
Health Risk |
Likely pathogenic |
— |
| RS2114241031 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS2114242538 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114242547 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114242907 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114242920 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS2114244815 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114247385 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114247458 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS2114247797 |
PEX6
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114248084 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114248288 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114248372 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2114276133 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114276308 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114276382 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114276465 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114276490 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114276588 |
COL10A1
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS2114276683 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114276718 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114276886 |
COL10A1
|
Health Risk |
Pathogenic |
— |
| RS2114276916 |
COL10A1
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS2114276983 |
COL10A1
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS2114277437 |
COL10A1
|
Health Risk |
Pathogenic |
— |
| RS2114277507 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114277685 |
COL10A1
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS2114277776 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114277790 |
COL10A1
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS2114277897 |
COL10A1
|
Health Risk |
Pathogenic |
— |
| RS2114278254 |
COL10A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2114278594 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114278703 |
COL10A1
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS2114278741 |
COL10A1
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, Schmid type |
| RS2114278893 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114278931 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114279043 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS2114283106 |
GJA1
|
Health Risk |
Likely pathogenic |
Oculodentodigital dysplasia, autosomal recessive |
| RS2114283459 |
GJA1
|
Health Risk |
Likely pathogenic |
Oculodentodigital dysplasia, Oculodentodigital dysplasia |
| RS2114283487 |
GJA1
|
Health Risk |
Likely pathogenic |
Oculodentodigital dysplasia, Oculodentodigital dysplasia |
| RS2114283819 |
GJA1
|
Health Risk |
Pathogenic |
Oculodentodigital dysplasia, Oculodentodigital dysplasia |
| RS2114320699 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114339116 |
TRDN
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2114357233 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2114391000 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114391108 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114403750 |
SEC63
|
Health Risk |
Likely pathogenic |
SEC63-related disorder, Autosomal dominant polycystic liver disease |
| RS2114406508 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114406531 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114420247 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114420319 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114426916 |
SEC63
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114432671 |
LAMA2
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy, Congenital muscular dystrophy |
| RS2114434218 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114436209 |
TRDN
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 5 |
| RS2114444927 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS2114445929 |
WASF1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with absent language and variable seizures, Neurodevelopmental disorder with absent language and variable seizures |
| RS2114446436 |
WASF1
|
Health Risk |
Likely pathogenic |
— |
| RS2114446923 |
SEC63
|
Health Risk |
Pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS2114447040 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114450848 |
LAMA2
|
Health Risk |
Likely pathogenic |
Proximal muscle weakness, Proximal muscle weakness |
| RS2114451064 |
LAMA2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS2114451604 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114453997 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114454119 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114458613 |
SEC63
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114458654 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114458929 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114459565 |
TNFAIP3
|
Health Risk |
Likely pathogenic |
— |
| RS2114460279 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114460969 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114461992 |
SEC63
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114462231 |
IFNGR1
|
Health Risk |
Pathogenic |
Disseminated atypical mycobacterial infection, Disseminated atypical mycobacterial infection |
| RS2114462360 |
IFNGR1
|
Health Risk |
Pathogenic |
Disseminated atypical mycobacterial infection, Disseminated atypical mycobacterial infection |
| RS2114469138 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS2114473419 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS2114476431 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114476485 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114476499 |
SEC63
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114478790 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114478944 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114485125 |
TNFAIP3
|
Health Risk |
Likely pathogenic |
— |
| RS2114487759 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2114489353 |
BVES
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2X, Autosomal recessive limb-girdle muscular dystrophy type 2X |
| RS2114490906 |
TNFAIP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoinflammatory syndrome, familial |
| RS2114491041 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2114493974 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2114494356 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114494398 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2114494623 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |